FDA Approves Abilify sNDA for Major Depressive Disorder
Posted on: Wednesday, 21 November 2007, 15:00 CST
Bristol-Myers Squibb and Otsuka Pharmaceutical have announced that the FDA has approved the supplemental new drug application for Abilify as adjunctive treatment to antidepressant therapy in adults with major depressive disorder.
This supplemental new drug application (sNDA) approval is based on results from two six-week, double-blind, randomized, placebo-controlled, multicenter studies. The results demonstrated significant improvement in depressive symptoms in adult patients with a primary diagnosis of major depressive disorder who had experienced an inadequate response to monotherapy with one or more antidepressant therapies in the current episode and then added Abilify to their treatment regimens.
Elliott Sigal, executive vice president, chief scientific officer and president, R&D, Bristol-Myers Squibb, said: "We are committed to helping those who suffer from depression, one of the leading causes of disability in the US and worldwide. This approval is a reflection of our ongoing commitment to provide innovative therapies, such as Abilify, to help adults living with depression."
Source: Datamonitor
Related Articles
- Lexapro Loses First-Line Position for the Treatment of Major Depression
- For Bipolar Depression, Surveyed Experts Indicate That Current and Emerging Therapies Have No Advantage Over Seroquel in Decreasing the Severity of Symptoms
- U.S. Food and Drug Administration Approves ABILIFY(R) (Aripiprazole) As the First Medication for Add-On Treatment of Major Depressive Disorder (MDD)
- Bristol-Myers/Otsuka: Abilify Receives Priority Review for MDD
- ABILIFY(R) (Aripiprazole) Supplemental New Drug Application Receives Priority Review By U.S. Food And Drug Administration for Adjunctive Treatment in Adults With Major Depressive Disorder
- New Hope for Manic-Depression Sufferers Comes From Unlikely Source
- Neuronetics Prepares for Market Launch of New Depression Therapy
- Abilify plus an antidepressant for mood disorders
- Coping With Depression a Fulltime Job, Football Star Learns
 |
 |
User Comments (0)
RSS Feeds